dRx series: deprescribing denosumab & bisphosphonates in older people


32387683 - osteoporosis - unhealthy bone structure
What’s the optimal duration of therapy with bisphosphonates and denosumab for individual older patients... and when and how should deprescribing be considered? Amanda Quek and Dr Amy Page take a look Deprescribing is defined as a person-centred process of medication withdrawal intended to achieve improved health outcomes through discontinuation of one or more medications that

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Opening the door: supporting men’s health in pharmacy
Next Building for a rosy future